In 2020–2021, a group of researchers from Gomel State Medical University conducted a prospective comparative clinical research that clearly demonstrates the differences in immunogenicity and reactogenicity of Sputnik V...
An interim analysis of data from a phase 3 clinical trial of Russia’s two-dose Gam-COVID-Vac (Sputnik V) coronavirus vaccine involving nearly 20,000 adult volunteers suggests an efficacy of 91.6% against...